prolyl hydroxylase inhibitor Recently Published Documents

Hypoxia-inducible factor prolyl hydroxylase inhibitor, C-terminal fibroblast growth factor 23 fragments, and hepcidin

Kidney International ◽

10.1016/j.kint.2021.04.038 ◽

2021 ◽

Vol 100 (3) ◽

pp. 709 ◽

Cited By ~ 1

Author(s):

Michele F. Eisenga

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor 23 ◽

Prolyl Hydroxylase ◽

Fibroblast Growth ◽

In Vitro and Clinical Pharmacokinetic Studies of the Effects of Iron-Containing Agents on Vadadustat, an Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.06.013 ◽

2021 ◽

Author(s):

Yoshimasa Kokado ◽

Kouji Kawai ◽

Takehiro Nanjo ◽

Shuji Kinoshita ◽

Kazuoki Kondo

Keyword(s):

Clinical Pharmacokinetic ◽

Prolyl Hydroxylase ◽

Pharmacokinetic Studies ◽

Effects of molidustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, on sodium dynamics in hypertensive subtotally nephrectomized rats

Journal of Pharmacological Sciences ◽

10.1016/j.jphs.2021.03.007 ◽

2021 ◽

Vol 146 (2) ◽

pp. 98-104

Author(s):

Anqi Zhang ◽

Daisuke Nakano ◽

Norihiko Morisawa ◽

Kento Kitada ◽

Wararat Kittikulsuth ◽

...

Keyword(s):

Prolyl Hydroxylase ◽

JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat

European Journal of Pharmacology ◽

10.1016/j.ejphar.2021.173990 ◽

2021 ◽

Vol 898 ◽

pp. 173990

Author(s):

Yuichi Shinozaki ◽

Kenji Fukui ◽

Hatsue Kobayashi ◽

Hiromi Yoshiuchi ◽

Akira Matsuo ◽

...

Keyword(s):

Comparative Study ◽

Prolyl Hydroxylase ◽

Recombinant Erythropoietin ◽

Anemia Of Inflammation ◽

Iron Utilization

In silico identification of prolyl hydroxylase inhibitor by per‐residue energy decomposition‐based pharmacophore approach

Journal of Cellular Biochemistry ◽

10.1002/jcb.29933 ◽

2021 ◽

Author(s):

Mahesh Kumar Teli ◽

Surendra Kumar ◽

Dharmendra Kumar Yadav ◽

Mi‐hyun Kim

Keyword(s):

In Silico ◽

Prolyl Hydroxylase ◽

Energy Decomposition ◽

In Silico Identification ◽

Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Vadadustat, an Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.927 ◽

2021 ◽

Author(s):

Ajit Chavan ◽

Leontia Burke ◽

Rishikesh Sawant ◽

Pamela Navarro‐Gonzales ◽

Dennis Vargo ◽

...

Keyword(s):

Hepatic Impairment ◽

Prolyl Hydroxylase ◽

Moderate Hepatic Impairment ◽

A validated method for the quantification of IOX‐2, a potent prolyl hydroxylase inhibitor in equine urine and plasma using liquid chromatography–high‐resolution mass spectrometry

Drug Testing and Analysis ◽

10.1002/dta.3010 ◽

2021 ◽

Author(s):

Ezra Mikhail ◽

Erik Siccardi ◽

Ali Bawazir ◽

Ambika Rajesh ◽

Seetharani Prathyush ◽

...

Keyword(s):

Mass Spectrometry ◽

Liquid Chromatography ◽

High Resolution ◽

High Resolution Mass Spectrometry ◽

Prolyl Hydroxylase ◽

High Resolution Mass ◽

Resolution Mass

Prolyl hydroxylase inhibitor desidustat protects against acute and chronic kidney injury by reducing inflammatory cytokines and oxidative stress

Drug Development Research ◽

10.1002/ddr.21792 ◽

2021 ◽

Author(s):

Amit A. Joharapurkar ◽

Vishal J. Patel ◽

Samadhan G. Kshirsagar ◽

Maulik S. Patel ◽

Hardikkumar H. Savsani ◽

...

Keyword(s):

Oxidative Stress ◽

Inflammatory Cytokines ◽

Kidney Injury ◽

Prolyl Hydroxylase ◽

Chronic Kidney Injury ◽

And Oxidative Stress

Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor

Gut Microbes ◽

10.1080/19490976.2021.1938380 ◽

2021 ◽

Vol 13 (1) ◽

pp. 1938380

Author(s):

Ruth X. Wang ◽

Morkos A. Henen ◽

J. Scott Lee ◽

Beat Vögeli ◽

Sean P. Colgan

Keyword(s):

Prolyl Hydroxylase ◽

Hif Prolyl Hydroxylase